Skip to content

Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease

Cerebellar rTMS Theta Burst for Dual-task Walking in Parkinson's Disease:a Double Blind Cross-over Sham-controlled Study Using Wearing Sensors Technology

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04238000
Enrollment
20
Registered
2020-01-23
Start date
2018-01-01
Completion date
2020-06-01
Last updated
2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Gait, Festinating, Parkinson, Parkinson Disease, Parkinsonism

Keywords

repetitive Transcranial Magnetic stimulation, rTMS, wearing sensors, wearables, step variability, gait variability, gait speed, dual-task, dual-task walking, turning

Brief summary

Objective of the study: To test the efficacy of theta burst cerebellar stimulation on dual task walking in Parkinson's disease using a cross-over design and wearing sensors technology Design: Twenty Parkinson's disease patients with no dementia will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days. Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology .

Detailed description

There are no medical effective treatments for dual-task gait in Parkinson's disease. Imaging, neurophysiology and pathology studies suggested cerebellum as possible target of brain stimulation for dual-task walking for theta Burst repetitive Transcranial magnetic stimulation Objective of the study: To test the efficacy of theta burst cerebellar stimulation on gait in Parkinson's disease using a cross-over design and wearing sensors technology Design: Parkinson's disease patients able to walk and without dementia/behavioral disturbances will be recruited for a cross-over sham-controlled study. Each patient will undergo a sham stimulation or a single session of cerebellar theta burst stimulation with a wash out period of at least 14 days. Repetitive cerebellar theta burst stimulation will be performed by Duo-Mag XT100, using a 3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals for a total of 600 pulses. Intensity of rTMS was set at the 80% of Amplitude of Motor Threshold (RMT) obtained in the left motor cortex for each subject. A sample size of 20 subjects with complete stimulation (2 stimulations per subject, for a total number of stimulation) Each patient will be evaluated before and after stimulation by a battery of gait and movement tests using wearing sensors technology. Sensors assessment: The following gait parameters will be evaluated in normal and cognitive/motor dual-tasks: i) step length ii) step variability iii) step phases iv) turning speed

Interventions

DEVICErepetitive transcranial magnetic stimulation

Cerebellar repetitive theta Burst stimulation will be performed as detailed in the Real arm description

Sponsors

University of Kiel
CollaboratorOTHER
Università degli Studi di Brescia
CollaboratorOTHER
Fondazione Europea di Ricerca Biomedica Ferb Onlus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

The patient and the examiner who administered the clinical scales were blind to the type of rTMS delivered, which was applied by another blinded experimenter.

Intervention model description

Each patient received both rTMS and sham cerebellar stimulation in randomized order in two different sessions, separated by at least 2 weeks. In each session, motor tasks, clinical scales and wearing sensor assessments were tested twice in all patients: at baseline (pre-stimulation) and after rTMS (post-stimulation)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* established Parkinson's disease * ability to stand alone and walk without support

Exclusion criteria

* dementia or behavioral alterations * contraindication to stimulation

Design outcomes

Primary

MeasureTime frameDescription
Step variability in dual-task walkingChanges from Baseline to immediately after stimulationStep variability will be assessed in normal, cognitive/motor dual-task conditions walking
Step length in dual-task walkingChanges from Baseline to immediately after stimulationStep length will be assessed in normal, cognitive/motor dual-task conditions
Gait speed in dual-task walkingChanges from Baseline to immediately after stimulationGait speed will be assessed in normal, cognitive/motor dual-task conditions

Secondary

MeasureTime frameDescription
Turning speed in timed up and go testsChanges from Baseline to immediately after stimulationTurning will be assessed y wearing sensors during timed up and go tests
total distance of dual-task walkingChanges from Baseline to immediately after stimulationThe total distance of one minute normal/motor/cognitive dual-task walking will be assessed

Countries

Italy

Contacts

Primary ContactAndrea Pilotto, MD
pilottoandreae@gmail.com00393396245281
Backup ContactCristina Rizzetti
rizzetti@hotmail.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026